Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Thank you for subscribing to
PMO
!
While you wait for the confirmation email to arrive in your inbox (which may take a minute or two), we encourage you to explore our website and read some of our recent articles.
Most Popular Articles
COMMANDS Study Results May Shift the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes
Serial Biopsies Identify Treatment Resistance and Inform Therapy Decisions in Patients with Advanced Solid Malignancies
Recent Advances in Therapeutic Targeting of NRG1 Fusion-Bearing Cancers
Biomarkers
Serial Biopsies Identify Treatment Resistance and Inform Therapy Decisions in Patients with Advanced Solid Malignancies
Recent Advances in Therapeutic Targeting of NRG1 Fusion-Bearing Cancers
Low-Grade Gliomas as a Model Malignancy for Preventing Oncogenic Signaling Through BRAF Inhibition
Biosimilars
Expanding Roles for Pathologists as Members of the Multidisciplinary Cancer Care Team
Kay Washington, MD, PhD
,
Safia N. Salaria, MD
It Doesn’t Get More Personal Than This: Patient’s Biospecimens Are the Sine Qua Non of Personalized Medicine
Carolyn Compton, MD, PhD, FCAP
Urine Assays Detect Early Mutations in Patients with Advanced Cancers
Immunotherapy
Applying CAR T-Cell Therapies to Solid Tumors: Overcoming Current Challenges
Chase Doyle
Evolving Immuno-Oncology Strategies in Renal-Cell Carcinoma
Wayne Kuznar
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
Chase Doyle
Back to Top